ARVYS Proteins

ARVYS Proteins

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $5M

Overview

ARVYS Proteins is a specialized CRO providing end-to-end custom protein services, from gene synthesis and expression to purification, characterization, and functional assay development. The company operates as a fee-for-service provider, catering primarily to the research and early-stage discovery needs of biopharma and academic clients. With a focus on technical expertise, aggressive timelines, and confidentiality, ARVYS positions itself as a flexible and high-quality partner in the highly fragmented protein services market. Its business model is based on generating revenue through contracted research services rather than developing its own therapeutic pipeline.

AntibodiesProteomicsDiagnostics

Technology Platform

Integrated suite of protein science capabilities including genetic engineering, multi-host recombinant protein expression (bacterial, yeast, insect, mammalian), purification, characterization, and functional assay development.

Funding History

1
Total raised:$5M
Seed$5M

Opportunities

Growing outsourcing trends in biopharma R&D and the increasing complexity of biologic drug targets create sustained demand for expert protein services.
Specializing in difficult-to-express proteins or expanding into GMP-grade production for pre-clinical materials could open higher-value market segments.

Risk Factors

Intense competition from numerous CROs and in-house biotech capabilities pressures pricing and client retention.
Revenue is entirely dependent on project-based contracts, making it susceptible to downturns in client R&D spending and project-specific scientific failures.

Competitive Landscape

ARVYS competes in a crowded market of protein service CROs, ranging from small boutique labs to large, diversified players like Lonza and Thermo Fisher. Its differentiation hinges on technical expertise, personalized service, and a broad multi-system expression capability, rather than scale or brand recognition.